BlackRock Amends Pulmonx Corp. Stake, Maintains Institutional Confidence
Ticker: LUNG · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1127537
| Field | Detail |
|---|---|
| Company | Pulmonx Corp (LUNG) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still holds Pulmonx stock, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Pulmonx Corp. common stock as of December 31, 2023. This filing, an amendment number 2, shows BlackRock continues to be a significant institutional holder, which can provide a sense of stability and institutional confidence in Pulmonx Corp. for current and prospective investors.
Why It Matters
This filing confirms BlackRock's continued significant investment in Pulmonx Corp., signaling that a major institutional investor still sees value in the company. This can reassure other investors and potentially influence stock stability.
Risk Assessment
Risk Level: low — This filing is routine for large institutional investors and does not indicate any immediate negative or positive risk, but rather confirms existing ownership.
Analyst Insight
An investor should note BlackRock's continued presence as a significant shareholder, which can be a positive signal of institutional confidence, but this filing alone doesn't warrant immediate action. It's a data point for broader due diligence.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Pulmonx Corp. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A amendment
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and '(Amendment No: 2)' in the filing.
Who is the 'reporting person' in this filing?
The 'reporting person' is BlackRock Inc., as stated under the 'FILED BY' section and on the cover page.
What is the 'subject company' of this filing?
The 'subject company' is Pulmonx Corp., as identified under the 'SUBJECT COMPANY' section and on the Schedule 13G form itself.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the Common Stock of Pulmonx Corp. is 745848101, as listed on the Schedule 13G cover page.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated on the Schedule 13G cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding Pulmonx Corp (LUNG).